Linden Capital-backed Specialty Networks, a pharmaceutical company in Cleveland, Ohio, agreed to acquire United Rheumatology, a national rheumatology network. Financial terms were not disclosed. "We are excited to welcome United Rheumatology into the Specialty Networks' family of companies. Our shared mission to help improve patient care by strengthening independent specialty providers makes this acquisition a great fit for both of our companies. With the acquisition of United Rheumatology, Specialty Networks adds a third specialty to its portfolio of specialty-focused companies," David Coury, Specialty Networks CEO.